Ascendis Pharma to Report FY 2025 Financial Results Feb. 11
Ascendis Pharma will report full-year 2025 financials and deliver a business update on February 11, 2026, after U.S. market...
eClinical Tech News
Adaptive Bio Reports Q4 and Full Year 2025 Financials
Adaptive Biotechnologies reported a breakout 2025: total revenue rose 55% to $277 million, driven by 46% growth in its...
Rhythm Announces Participation in Guggenheim Biotech Summit
Rhythm Pharmaceuticals will put its finance chief on stage next week. The company’s CFO is scheduled for a fireside...
Novartis Delivered Strong Sales Growth and 40% Core Margin
Novartis closed 2025 with net sales of $54.5 billion, up 8% in constant currencies, core operating income up 14%,...
NMD Pharma Announces Topline Results from Phase 2a CMT Study
NMD Pharma reported topline Phase 2a results from SYNAPSE-CMT, a randomized, double-blind, placebo-controlled study of ignaseclant, its first-in-class skeletal...
Ignaseclant CMT Trial: NMD Pharma Announces Topline Results
NMD Pharma reported topline Phase 2a results for ignaseclant in Charcot-Marie-Tooth disease (CMT) types 1 and 2. The randomized,...
Novartis Delivered Strong Sales Growth & 40% Margin in 2025
Novartis posted full-year 2025 net sales of $54.5 billion, up 8% at constant currency, with core operating income rising...
Pharma Co. Expands Arakoda Access with GoodRx Partnership
60 Degrees Pharmaceuticals has partnered with GoodRx to offer up to 30% savings on Arakoda (tafenoquine), the once-weekly, FDA‑approved...
Announcing Cormedix Therapeutics Share Repurchase Program
CorMedix Therapeutics has authorized a share repurchase program of up to $75 million through December 31, 2027, with purchases...
Spectral AI Announces Burn Awareness Week 2026 Participation
Spectral AI will join the American Burn Association’s National Burn Awareness Week, aligning a workplace-focused prevention campaign with its...